Hillary Brunner
Foot Surgery · Odessa, TXNPI 1992834261
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Anika Therapeutics, Inc. at 47.2% of the total. Reporting peaked in 2021 at $1,232 and has fallen 74.0% since, to $320 in 2025.
Across 43 payments — averaging $62.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$1K
- Treace Medical Concepts, Inc.$747
- Smith+Nephew$128
- Integra Lifesciences Corporation$98
- Arthrosurface Incorporated$82
- Vertex$82
- plus $286 from 10 others
What the payments were for
- Travel & lodging$1,30849%
- Food & beverage$1,38651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 9 | $1,271 |
| Treace Medical Concepts, Inc. | 8 | $747 |
| Smith+Nephew | 4 | $128 |
| Integra Lifesciences Corporation | 3 | $98 |
| Arthrosurface Incorporated | 1 | $82 |
| Vertex | 3 | $82 |
| Tactile Systems Technology Inc | 3 | $59 |
| Paratek Pharmaceuticals, Inc. | 3 | $57 |
| Advanced Oxygen Therapy Inc. | 2 | $32 |
| Orthofix Medical, Inc. | 1 | $24 |
| Convatec Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| Amgen | 1 | $23 |
| Bioventus LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Organogenesis Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemiCAP$600
- TACTOSET$525
- Lapiplasty System$498
How this compares
$2,693 in reported general payments places this provider in the 55th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 48 | $12,329 |
| SantylCollagenase Clostridium Hist. | 15 | $5,898 |
| Doxycycline Hyclate | 280 | $3,431 |
| Betamethasone Dipropionate | 25 | $1,206 |
| SsdSilver Sulfadiazine | 119 | $917 |
| Silver Sulfadiazine | 112 | $772 |
| Gabapentin | 83 | $771 |
| Ciprofloxacin Hcl | 67 | $692 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 44 | $666 |
| Duloxetine Hcl | 26 | $509 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 28 | $458 |
| Nabumetone | 14 | $443 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $366 |
| Pregabalin | 12 | $363 |
| Diclofenac Sodium | 14 | $271 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $128 | $5,89815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 71 foot surgery providers in Texas.
Other foot surgery in Odessa
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
- Richard GalperinDallas$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.